Treating Colon Cancer Cells with FK228 Reveals a Link between Histone Lysine Acetylation and Extensive Changes in the Cellular Proteome

The therapeutic value of FK228 as a cancer treatment option is well known, and various types of cancer have been shown to respond to this drug. However, the complete mechanism of FK228 and the affect it has on histone lysine acetylation and the colon cancer cell proteome are largely unknown. In the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tian-yun, Jia, Yan-long, Zhang, Xi, Sun, Qiu-li, Li, Yi-Chun, Zhang, Jun-he, Zhao, Chun-peng, Wang, Xiao-yin, Wang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682073/
https://www.ncbi.nlm.nih.gov/pubmed/26675280
http://dx.doi.org/10.1038/srep18443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682073/
https://www.ncbi.nlm.nih.gov/pubmed/26675280
http://dx.doi.org/10.1038/srep18443

Ejemplares similares